HeXun Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 23, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,482	3,105	2,981	-	-
Market Cap Growth	4.17%	4.17%	-	-	-
Enterprise Value	3,144	2,861	2,763	-	-
Last Close Price	75.70	67.50	64.80	-	-
PE Ratio	23.66	21.09	89.01	-	-
PS Ratio	12.16	10.84	22.83	-	-
PB Ratio	5.61	5.00	6.30	-	-
P/TBV Ratio	5.86	5.23	6.79	-	-
P/FCF Ratio	41.64	37.13	132.95	-	-
P/OCF Ratio	28.80	25.68	69.18	-	-
EV/Sales Ratio	10.98	9.99	21.16	-	-
EV/EBITDA Ratio	17.54	16.27	64.08	-	-
EV/EBIT Ratio	20.19	18.37	100.94	-	-
EV/FCF Ratio	37.60	34.21	123.24	-	-
Debt / Equity Ratio	0.06	0.06	0.15	0.23	0.35
Debt / EBITDA Ratio	0.20	0.20	1.56	13.75	-
Debt / FCF Ratio	0.42	0.42	3.24	7.16	-
Asset Turnover	0.45	0.45	0.27	0.14	-
Inventory Turnover	2.55	2.55	-	-	-
Quick Ratio	8.51	8.51	11.67	9.82	10.87
Current Ratio	8.99	8.99	12.05	10.55	11.94
Return on Equity (ROE)	26.92%	26.92%	8.50%	-1.96%	-
Return on Assets (ROA)	15.23%	15.23%	3.51%	-1.61%	-
Return on Capital (ROIC)	16.20%	16.20%	3.67%	-1.66%	-
Return on Capital Employed (ROCE)	23.80%	23.80%	5.10%	-	-
Earnings Yield	4.23%	4.74%	1.12%	-	-
FCF Yield	2.40%	2.69%	0.75%	-	-
Buyback Yield / Dilution	-1.61%	-1.61%	-20.81%	-22.92%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.